AI assistant
CorMedix Inc. — Director's Dealing 2012
Sep 28, 2012
32333_dirs_2012-09-28_a02b09fa-767a-49c7-8138-80095d55865b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2012-09-20
Reporting Person: Lefkowitz Steven W (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Senior Convertible Note (convertible into common stock) | $ | n/a () | 0 | Direct | |
| Warrant (right to purchase common stock) | $ | n/a () | 0 | Direct |
Footnotes
F1: On September 24, 2012, the reporting person mistakenly reported on a Form 4 (the "Form 4") the purchase of $15,000 of (i) 9% Senior Convertible Notes, convertible into shares of the Company's common stock at a conversion price of $0.35 per share (the "Notes"); and (ii) a five-year redeemable warrant to purchase common stock at an exercise price of $0.40 per share (the "Warrant"). The reporting person deposited $15,000 in escrow for such purchase, which will remain in escrow until the final closing, if any, as determined by the Company. The disclosure in the Form 4 regarding the purchase of $35,000 of the Notes and the Warrant by the reporting person, indirectly through Wade Capital Corporation, is accurate.